Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to -$431000.0.

  • Phibro Animal Health's Gains from Investment Securities rose 8660.24% to -$431000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $21.0 million, marking a year-over-year increase of 5428.63%. This contributed to the annual value of $4.5 million for FY2025, which is 0.0% changed from last year.
  • According to the latest figures from Q4 2025, Phibro Animal Health's Gains from Investment Securities is -$431000.0, which was up 8660.24% from $3.7 million recorded in Q3 2025.
  • In the past 5 years, Phibro Animal Health's Gains from Investment Securities registered a high of $19.3 million during Q2 2024, and its lowest value of -$3.2 million during Q4 2024.
  • In the last 5 years, Phibro Animal Health's Gains from Investment Securities had a median value of $509500.0 in 2021 and averaged $4.5 million.
  • Per our database at Business Quant, Phibro Animal Health's Gains from Investment Securities soared by 201538.46% in 2021 and then plummeted by 41035.6% in 2023.
  • Quarter analysis of 5 years shows Phibro Animal Health's Gains from Investment Securities stood at $1.8 million in 2021, then crashed by 173.16% to -$1.3 million in 2022, then dropped by 15.62% to -$1.6 million in 2023, then tumbled by 107.01% to -$3.2 million in 2024, then surged by 86.6% to -$431000.0 in 2025.
  • Its last three reported values are -$431000.0 in Q4 2025, $3.7 million for Q3 2025, and $17.2 million during Q2 2025.